STUMPTOWN STRATEGIES

Lobbying for PRIME THERAPEUTICS · Healthcare

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Minnesota · House · Senate · $20,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

PBM issues - Transparency, Delinking HR 2214 Drug Act

Pharmacy

HR 2214 DRUG Act Delinking, PBM Issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.